Apr.05.2021
Corporate

Announcement on Changes of Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers

PDF(398 KB)

　Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara) announced that the Company decided the following changes of Members of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at its Board of Directors Meeting held today.
　The appointments for candidates of Members of the Board of Directors and Audit & Supervisory Board Members will be resolved at the 73rd Annual Shareholders Meeting Scheduled for the mid of June 2021. The changes and appointments of Members of the Board of Directors, Standing Audit & Supervisory Board Members and Corporate Officers will be officially decided at the Board of Directors Meeting to be held on the same day of the Annual Shareholders Meeting.

  1. Changes of Members of the Board of Directors (as of mid of June 2021)
    Incumbent Members of the Board of Directors will be re-appointed.

    • 1.1　New candidate of Members of the Board of Directors

      　　- Kiyoaki Idemitsu　　 Corporate Executive Officer, Executive Director, Clinical Development

      　　- Outside Members of the Board of Directors

      Name Shusaku Nagae
      Date of Birth January 30, 1950
      Career
      Summary      		 Apr. 1972　　Joined Matsushita Electric Works, Ltd. (MEW)
      Dec. 2004　　Managing Executive Officer, MEW
      Jun. 2007　　Managing Director, Member of the Board, MEW
      Jun. 2010　　President, Panasonic Electric Works, Ltd.
      Apr. 2011　　Senior Managing Executive Officer, Panasonic Corporation (PC)
      Jun. 2012　　Executive Vice President, Member of the Board, PC
      Jun. 2013　　Representative Director and Chairman of the Board, PC
      Jun. 2017　　Chairman of the Board, PC (to date)
      [Important concurrent post]
      Director, Chairman of the Board, PC (Planned to retire in Jun. 2021)
      Chairman, Vehicle Information and Communication System Center, a general incorporated foundation
      Reasons for nomination Mr. Shusaku Nagae has extensive experience and insight as a corporate manager over many years. Since the Company can expect his appropriate supervision on our management from an independent standpoint and valuable advice and suggestion regarding overall corporate management through his experience and insight, we have nominated him as an outside Member of the Board of Directors candidate.
    • 1-2　Resigning Members of the Board of Directors

      　　- Hiroshi Awata　　 Vice President, Executive Officer, Tokyo Branch Head
      　　　　　　　　　　　　* After resigning, he will be appointed as a senior partner.

      　　- Jun Kurihara　　 Outside Members of the Board of Director

  2. Audit & Supervisory Board Members (as of mid of June 2021)

    • 2-1　New candidate of Outside Audit & Supervisory Board Member (current post in the bracket)

      　　- Hironobu Tanisaka (full-time) 　　(Currently: Director, Business Audit Department)
       

    • 2-2　Resigning outside Audit & Supervisory Board Members (voluntarily)

      　　- Shinji Fujiyoshi (full-time)　　 (Currently: Audit & Supervisory Board Member)
      　　　　　　　　　　　　* After resigning, he will be appointed as a part-time adviser.
       

  3. Changes of Corporate Officers (as of mid of June 2021)
    Except for the following candidates of Corporate Officers, incumbent Corporate Officers will be re-appointed.

    • 3-1　New candidates of Corporate Officer

      　　- Masaki Ito　　 Director, Corporate Planning Department
       

    • 3-2　Resigning Corporate Officers

      　　- Katsunori Morio　　 Corporate Officer, Division Director, Sales Division, Metropolitan Region
      　　　　　　　　　　　　* After resigning, he will be appointed as a full-time adviser.

      　　- Takuya Seko　　 Officer, Chief Officer, Quality Assurance Management
      　　　　　　　　　　　　* After resigning, he will be appointed as an Officer.

＜Reference＞
The followings are the appointments of Members of the Board of Directors, Audit & Supervisory Board Members, and Corporate Officers (as of mid of June 2021).
　*: Candidates of Members of the Board of Directors and Audit & Supervisory Board Members for subject to approval at the 73rd Annual Shareholders Meeting

Members of the Board of Directors：
- Gyo Sagara*　　President, Representative Director
- Isao Ono*　　Executive Officer, Director, Corporate Research<
- Toshihiro Tsujinaka*　　Executive Director, Corporate Strategy & Planning
- Toichi Takino*　　Executive Director, Discovery & Research
- Kiyoaki Idemitsu*　　Executive Director, Clinical Development
- Masao Nomura*　　Outside Director
- Akiko Okuno*　　Outside Director
- Shusaku Nagae*　　Outside Director

Audit & Supervisory Board Members：
- Katsuyoshi Nishimura　　 Audit & Supervisory Board Member (full-time)
- Hironobu Tanisaka*　　 Audit & Supervisory Board Member (full-time)
- Yasuo Hishiyama 　　Outside Audit & Supervisory Board Member
- Akiko Tanabe　　 Outside Audit & Supervisory Board Member

Corporate Officers：
- Hiroshi Ichikawa　　 Corporate Senior Executive Officer, Executive Director, Sales and Marketing
- Yukio Tani　　 Corporate Executive Officer, Head of Corporate Communications
- Shozo Matsuoka　　 Corporate Executive Officer, Executive Director, Corporate Regulatory Compliance, Safety and Quality Assurance
- Katsuji Teranishi　　 Corporate Officer, Division Director, Sales Division, Western Japan Region
- Hiromu Habashita　　 Corporate Officer, Deputy Executive Director, Discovery & Research
- Shinji Takai　　 Corporate Officer, Head of Medical Affairs / Head of Data Strateg
- Keiji Masui　　 Corporate Officer, Division Director, Sales Division, Eastern Japan Region
- Masaki Ito　　 Corporate Officer, Director, Corporate Planning Department

Back to List